GREATWALL vs GeneFerm Biotechnology: monthly revenue

Monthly revenue and year-on-year change for GREATWALL (1210) and GeneFerm Biotechnology (1796) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GREATWALL ━ GeneFerm Biotechnology

0%+40%-13%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGREATWALLYoYGeneFerm BiotechnologyYoY
Oct 2026NT$9.66 billion+14.6%NT$58.5 million+0.1%
Sep 2026NT$9.88 billion+13.2%NT$48.2 million-12.4%
Aug 2026NT$9.7 billion+13.4%NT$57.3 million-10.9%
Jul 2026NT$9.64 billion+21.5%NT$64.6 million+39.8%
Jun 2026NT$8.95 billion+12.2%NT$70.6 million+22.8%
May 2026NT$9.07 billion+10.2%NT$46.9 million-8.9%
Apr 2026NT$9.1 billion+4.3%NT$51.4 million-12.6%
Mar 2026NT$9.21 billion+5.0%NT$52.8 million-12.9%
Feb 2026NT$7.63 billion-5.7%NT$46 million+2.7%
Jan 2026NT$9.73 billion+12.0%NT$54.4 million-10.8%
Dec 2025NT$9.59 billion+4.6%NT$61.9 million+11.6%
Nov 2025NT$8.86 billion-1.2%NT$56.9 million+19.7%
Oct 2025NT$8.43 billion-2.0%NT$58.5 million+12.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16